Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IBERDOMIDE vs IBREXAFUNGERP: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

IBERDOMIDE vs IBREXAFUNGERP: Safety Overview

Metric IBERDOMIDE IBREXAFUNGERP
Total FAERS Reports 107 129
Deaths Reported 5 6
Death Rate 4.7% 4.7%
Hospitalizations 72 9
Average Patient Age 63.7 yrs 44.4 yrs
% Female Patients 45.0% 85.2%
FDA Approval Date N/A Jun 1, 2021
Marketing Status N/A Prescription